Welcome to IntegraGen's News and Events page. Here you will find current and archived press releases, listings of upcoming events, and news coverage about the company and some of its projects and initiatives.

Contact us if you would like more information about IntegraGen and our efforts.

GoPath Labs Announces North American Launch of miR-31-3p expression test

GoPath Laboratories, IntegraGen’s licensing partner in the U.S., has announced that it will launch a propriety new test, miR-31now™ during the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting being held June 1-5, 2018 in Chicago. The miR-31now test is the first positive theranostic test for patients with (…)  » 

IntegraGen to attend ASCO 2018 – June 1st to 5th in Chicago

IntegraGen will be in attendance at 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago from June 1st to June 5th.  The Annual ASCO Meeting brings together more than 32,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new (…)  » 

IntegraGen Achieves ISO 13485:2016 Certification for the Design, Manufacturing and Distribution of In Vitro Diagnostic Kits

IntegraGen announced that it has earned ISO 13485:2016 certification from Bureau Veritas. This certification indicates that the company’s quality management systems meet the specific standards required for the design, development, production and marketing of in vitro diagnostic kits, and lays the foundation for a continuous improvement process for in (…)  » 

Technical Validation Data for miR-31-3p test Published in Biomarker Insights

IntegraGen is pleased to announce that a comprehensive summary of the results of validation studies associated with the company’s proprietary miR-31-3p expression test has been published online in Biomarker Insights following peer-review.

The paper entitled “Technical validation of a reverse-transcription quantitative polymerase chain reaction in vitro (…)  » 

IntegraGen and Twist Bioscience Expand Partnership with Distribution Agreement for SIRIUS and MERCURY Genomic Data Analysis Tools

IntegraGen announces a global distribution agreement with Twist Bioscience for IntegraGen’s portfolio of genomic data analysis tools. The agreement includes distribution rights for SIRIUS™, an online Big Data solution that assists researchers to quickly and intuitively analyze exome data for Mendelian and oncology applications, and MERCURY™, an online (…)  » 

IntegraGen Partners with Twist Bioscience

IntegraGen today announced the addition of Twist Bioscience Corporation’s Human Core Exome Complete Kit, a streamlined library prep and exome enrichment solution, to its next-generation targeted sequencing product offerings. Under the terms of the agreement Twist Bioscience will provide IntegraGen its Human Core Exome Complete Kit for all target (…)  »